微RNA调控肿瘤多药耐药机制的研究进展
网络出版日期: 2016-05-26
基金资助
上海交通大学医学院大学生创新训练计划(2014027);国家级大学生创新创业训练计划(201510248065)
Research progresses of mechanisms for the regulation of tumor cell multi-drug resistance by miRNA
Online published: 2016-05-26
Supported by
Undergraduate Innovation Training Program of Shanghai Jiao Tong University School of Medicine, 2014027; National Undergraduate Training Program for Innovation and Entrepreneurship, 201510248065
张平辰 , 盛小楠 , 林正钰 , 程雨龙 , 许伟榕 . 微RNA调控肿瘤多药耐药机制的研究进展[J]. 上海交通大学学报(医学版), 2016 , 36(5) : 776 . DOI: 10.3969/j.issn.1674-8115.2016.05.032
MicroRNA (miRNA) is a vital regulator for gene expression in eukaryotes, as well as an important component in the regulatory mechanism of tumor drug resistance. miRNA can abnormally regulate target genes through membrane receptor-mediated drug efflux, alteration of drug targets, block of cell apoptotic pathways, and change in DNA repair ability, etc., thus involving in the regulatory mechanism of multi-drug resistance. Important research advances in the regulation of growth and differentiation of cancer stem cells and the induction of multi-drug resistance via triggering the protective autophage by miRNA have been achieved. This paper reviews recent research progresses of mechanisms for the regulation of tumor cell multi-drug resistance by miRNAs.
Key words: microRNA; cancer; multidrug resistance
/
〈 |
|
〉 |